Glaukos
GKOS
51 hedge funds and large institutions have $357M invested in Glaukos in 2015 Q2 according to their latest regulatory filings, with 51 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
40.52% more ownership
Funds ownership: 0% → 40.52% (+41%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MCAI
Meritech Capital Associates III
Palo Alto,
California
|
+$87.9M |
| 2 |
O
OrbiMed
New York
|
+$84.2M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
+$36.9M |
| 4 |
GGHC
Gilder Gagnon Howe & Co
New York
|
+$29.6M |
| 5 |
Jennison Associates
New York
|
+$16.9M |
Top Sellers
GKOS Hedge Fund Activity: Q2 2015 in Review
51 of the 3,730 institutional investors tracked by Wall St. Rank reported a position in Glaukos (GKOS) for Q2 2015, worth a combined $357M.
Buyers outnumbered sellers: 51 funds opened new GKOS positions and 0 closed out — a net gain of 51 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Meritech Capital Associates III, opening a new position worth an estimated $87.9M.
- 51 institutional investors held Glaukos (GKOS) as of Q2 2015, up from 0 in Q1 2015.
- Funds reported $357M of Glaukos stock for Q2 2015.
- 51 funds opened new Glaukos positions in Q2 2015 and 0 closed out, a net change of +51 holders.
- The largest Glaukos buyer in Q2 2015 was Meritech Capital Associates III, an estimated $87.9M added.
Based on aggregated 13F filings for Q2 2015.